Merck & Co. (MRK)
(Delayed Data from NYSE)
$125.85 USD
-0.07 (-0.06%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $125.87 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 261 - 280 ( 398 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Three Notable Areas of Development in Companion Animal Health; Our Takeaways from VMX 2018
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
A New Wave of Biotechs Reshaping the Animal Health Market; Initiate Coverage on Aratana and Kindred Bio With Buy Ratings
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S